Literature DB >> 21785974

Association of PPAR polymorphisms with cytokine levels in allergic rhinitis.

Magdolna Krasznai1, Kinga Szaniszlo, Helga Kraxner, Eszter Vargha, Margit Kovacs, Edit Kaszas, Gyorgyi Mezei, Endre Cserhati, Zoltan Borocz, Karoly Cseh.   

Abstract

Our aim was to study the association of Pro12Ala and exon6 C161T polymorphisms of PPARgamma and intron7 G/C polymorphisms of PPAR-alpha with clinical symptoms, peak nasal inspiratory flow values, serum soluble TNF-alpha, TNF-R1, Fas, Fas ligand and IgE concentrations in patients with seasonal allergic rhinitis during and after pollen season. We performed a follow-up study of 66 Hungarian patients with seasonal allergic rhinitis and 180 healthy referent subjects. We used PCR-RFLP technique and ELISA. The distribution of mutant alleles of PPAR-gamma and -alpha did not differ in patients and referent subjects. Patients carrying the mutant 12Ala, exon6 161T alleles of PPAR-gamma and intron7 C allele of PPAR-alpha had significantly higher clinical symptom score values, TNF-alpha and IgE levels and lower peak nasal inspiratory flow values during and after pollen season. The results indicated that nuclear receptors PPAR-gamma and PPAR-alpha are involved in the regulation of inflammatory mediator production in patients with seasonal allergic rhinitis and polymorphisms of the receptors are very likely to contribute to the heterogeneity of clinical and immunological parameters of allergic patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785974     DOI: 10.1007/s00405-011-1710-z

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  21 in total

1.  Serum-soluble Fas antigen level in patients with allergic rhinitis: its relation to specific immunotherapy.

Authors:  Gülay Kinikli; Aşkin Ateş; Murat Turgay; Nergis Aydoğan; Güner Tokgöz
Journal:  Allergy Asthma Proc       Date:  2006 Mar-Apr       Impact factor: 2.587

2.  Lower airways inflammation in allergic rhinitics: a comparison with asthmatics and normal controls.

Authors:  J L Brown; A F Behndig; B E Sekerel; J Pourazar; A Blomberg; F J Kelly; T Sandström; A J Frew; S J Wilson
Journal:  Clin Exp Allergy       Date:  2007-05       Impact factor: 5.018

3.  Cytokine pattern in allergic and non-allergic chronic rhinosinusitis in asthmatic children.

Authors:  A M Riccio; M A Tosca; C Cosentino; E Pallestrini; F Ameli; G W Canonica; G Ciprandi
Journal:  Clin Exp Allergy       Date:  2002-03       Impact factor: 5.018

4.  Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.

Authors:  X L Wang; J Oosterhof; N Duarte
Journal:  Cardiovasc Res       Date:  1999-12       Impact factor: 10.787

5.  Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.

Authors:  Yatrik M Shah; Keiichirou Morimura; Frank J Gonzalez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-11-09       Impact factor: 4.052

6.  Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages.

Authors:  Kazuhiro Asada; Shigekazu Sasaki; Takafumi Suda; Kingo Chida; Hirotoshi Nakamura
Journal:  Am J Respir Crit Care Med       Date:  2003-10-16       Impact factor: 21.405

7.  Peroxisome proliferator-activated receptors as novel targets in lung disease.

Authors:  Maria G Belvisi; David J Hele
Journal:  Chest       Date:  2008-07       Impact factor: 9.410

8.  A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

Authors:  S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

Review 9.  Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation.

Authors:  Shigeharu Ueki; Yoshinori Matsuwaki; Hiroyuki Kayaba; Hajime Oyamada; Akira Kanda; Atsuko Usami; Norihiro Saito; Junichi Chihara
Journal:  Int Arch Allergy Immunol       Date:  2004-06       Impact factor: 2.749

10.  Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation.

Authors:  Gaetane Woerly; Kohei Honda; Marc Loyens; Jean-Paul Papin; Johan Auwerx; Bart Staels; Monique Capron; David Dombrowicz
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  1 in total

1.  The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles.

Authors:  Zohreh Rahimi; Foroogh Chamaie-Nejad; Shohreh Saeidi; Ziba Rahimi; Ali Ebrahimi; Ebrahim Shakiba; Asad Vaisi-Raygani
Journal:  Int J Fertil Steril       Date:  2018-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.